LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.36 | 27.76 | 705 | 320 | 2.2007 | 1.5010 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.06 | 27.76 | 872 | 360 | 2.4222 | 1.5407 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.06 | 27.76 | 18 | 360 | 0.0500 | -0.1106 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.06 | 27.76 | 770 | 360 | 2.1389 | 1.4566 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.76 | 27.76 | 958 | 401 | 2.3882 | 1.5070 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.76 | 27.76 | 30 | 401 | 0.0748 | 0.0204 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.76 | 27.76 | 827 | 401 | 2.0616 | 1.4131 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.46 | 27.76 | 1012 | 438 | 2.3071 | 1.4672 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.46 | 27.76 | 65 | 438 | 0.1482 | 0.2382 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.46 | 27.76 | 921 | 438 | 2.0997 | 1.4095 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.17 | 27.76 | 1098 | 489 | 2.2451 | 1.4316 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.17 | 27.76 | 99 | 489 | 0.2024 | 0.3596 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.17 | 27.76 | 973 | 489 | 1.9895 | 1.3616 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.87 | 27.76 | 3 | 604 | 0.0050 | -0.3938 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.87 | 27.76 | 1179 | 604 | 1.9497 | 1.3241 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.87 | 27.76 | 260 | 604 | 0.4300 | 0.6541 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.87 | 27.76 | 988 | 604 | 1.6338 | 1.2335 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 15.58 | 27.76 | 6 | 685 | 0.0088 | -0.2819 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 15.58 | 27.76 | 1230 | 685 | 1.7941 | 1.2694 | MN20160318_Q01 | I15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 15.58 | 27.76 | 632 | 685 | 0.9219 | 0.9651 | MN20160318_Q01 | M03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 15.58 | 27.76 | 1129 | 685 | 1.6468 | 1.2277 | MN20160318_Q01 | M03 |